Home / Recalls / Medical Devices
Remel Inc recalls Oxoid Nitrocefin (+ Reconstitution Fluid Batch) REF: SR0112C, Oxoid Ltd. For the rapid chromogenic detection of beta-la
Recalled June 15, 2016 · FDA recall Z-1921-2016 · Remel
Hazard
Individual bottles of product may produce weak beta-lactamase reactions. Use may result in delayed or false negative reporting. · FDA Class II
Units
2 units were imported and distributed domestically
Sold at
US distribution in MO.
Description
Individual bottles of product may produce weak beta-lactamase reactions. Use may result in delayed or false negative reporting.
Product
Oxoid Nitrocefin (+ Reconstitution Fluid Batch) REF: SR0112C, Oxoid Ltd. For the rapid chromogenic detection of beta-lactamase activity in bacterial cells. in vitro diagnostic
Manufacturer(s)
Remel Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →